Crossmark

SPAG5 is a potential therapeutic target affecting proliferation, apoptosis, and invasion of esophageal cancer cells

Published Online: 2024-12-19

Authors

Zhang, Xiaohui

Zhang, Lingmin

Cui, Manli

Ji, Shiyu

Zhang, Yanan

Li, Qian

Zhang, Mingxin
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Received: 17 October 2024

Accepted: 28 November 2024

First Online: 19 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current